Cannon Gillian
- SEC CIK
- 0001833910
In the past year, 1 open-market sale filing worth $63.2K and no purchases.
Current role at each company
- XENE Xenon Pharmaceuticals Inc.Directoras of Jun 8, 2026
- CORT Corcept Therapeutics IncDirectoras of Sep 11, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $63.2K
- 1 filing
- Net
- −$63.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cannon Gillian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XENE Xenon Pharmaceuticals Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 (view filing) | Jun 5 | 3 days | Cannon GillianDirector | SSale | −1.19K | $53.14 | −$63.2K | −45.0%1.46K after | 10b5-1 |